British Society for Sexual Medicine guidelines on the management of erectile dysfunction.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Sexual Medicine

• Publication date

  2008-08-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1743-6109.2008.00773.xPMID 18298470
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Investigation, treatment, and monitoring of late-onset hypogonadism in males: ISA, ISSAM, EAU, EAA, and ASA recommendations.

  2009cited by this paper
• Diagnosis of Erectile Dysfunction

  2008cited by this paper
• Hormones, Metabolism, Aging and Men's Health

  2008cited by this paper
• Injection therapy for the treatment of erectile dysfunction: a comparison between alprostadil and a combination of vasoactive intestinal polypeptide and phentolamine mesilate

  2007cited by this paper
• National Institute for clinical excellence preoperative tests: Is the consensus hard to get?: 1AP3-9

  2007cited by this paper
• Priapism Associated with Multiple Psychotropics : A Case Report and Review of the Literature

  2007cited by this paper
• Management of Erectile Dysfunction in Clinical Practice

  2007cited by this paper
• A critical analysis of nonsurgical treatment of Peyronie's disease.

  2006cited by this paper
• Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

  2006cited by this paper
• Priapism: New concepts in the pathophysiology and new treatment strategies

  2006cited by this paper
• Are androgens critical for penile erections in humans? Examining the clinical and preclinical evidence.

  2006cited by this paper
• Combining testosterone and PDE5 inhibitors in erectile dysfunction: basic rationale and clinical evidences.

  2006cited by this paper
• Association of specific symptoms and metabolic risks with serum testosterone in older men.

  2006cited by this paper
• The second Princeton consensus on sexual dysfunction and cardiac risk: new guidelines for sexual medicine.

  2006cited by this paper
• Prospective, randomized, open-label, fixed-dose, crossover study to establish preference of patients with erectile dysfunction after taking the three PDE-5 inhibitors.

  2006cited by this paper
• EAU Guidelines on erectile dysfunction: an update.

  2006cited by this paper
• The evolving role of testosterone in the treatment of erectile dysfunction

  2006cited by this paper
• Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

  2006cited by this paper
• Erectile dysfunction--an observable marker of diabetes mellitus? A large national epidemiological study.

  2006cited by this paper
• Adjunctive use of AndroGel (testosterone gel) with sildenafil to treat erectile dysfunction in men with acquired androgen deficiency syndrome after failure using sildenafil alone.

  2006cited by this paper
• Low serum testosterone and mortality in male veterans.

  2006cited by this paper
• Ocular safety in patients using sildenafil citrate therapy for erectile dysfunction.

  2006cited by this paper
• Hypoactive sexual desire disorder in menopausal women: a survey of Western European women.

  2006cited by this paper
• The effect of tadalafil on psychosocial outcomes in Swedish men with erectile distress: a multicentre, non‐randomised, open‐label clinical study

  2006cited by this paper
• Calculated bioavailable testosterone levels and depression in middle-aged men.

  2006cited by this paper
• Comparing vardenafil and sildenafil in the treatment of men with erectile dysfunction and risk factors for cardiovascular disease: a randomized, double-blind, pooled crossover study.

  2006cited by this paper
• Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients.

  2005cited by this paper
• Bicycle riding and erectile dysfunction: an increase in interest (and concern).

  2005cited by this paper
• Erectile dysfunction and subsequent cardiovascular disease.

  2005cited by this paper
• Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES) study.

  2005cited by this paper
• EAU GuidelinesInvestigation, Treatment and Monitoring of Late-Onset Hypogonadism in Males: ISA, ISSAM, and EAU Recommendations

  2005cited by this paper
• Chapter 1: The management of erectile dysfunction: an AUA update.

  2005cited by this paper
• The use of an erectogenic pharmacotherapy regimen following radical prostatectomy improves recovery of spontaneous erectile function.

  2005cited by this paper
• ORIGINAL RESEARCH—PHARMACOTHERAPY: Successful Withdrawal of Oral Long‐Acting Nitrates to Facilitate Phosphodiesterase Type 5 Inhibitor Use in Stable Coronary Disease Patients with Erectile Dysfunction

  2005cited by this paper
• Sexual dysfunction and cardiac risk (the Second Princeton Consensus Conference).

  2005cited by this paper
• The impact on clinical practice of routine screening for macroprolactin.

  2005cited by this paper
• External vacuum therapy for erectile dysfunction: use and results

  2005cited by this paper
• An open‐label, multicentre, randomized, crossover study comparing sildenafil citrate and tadalafil for treating erectile dysfunction in men naïve to phosphodiesterase 5 inhibitor therapy

  2005cited by this paper
• Successful withdrawal of oral long-acting nitrates to facilitate phosphodiesterase type 5 inhibitor use in stable coronary disease patients with erectile dysfunction.

  2005cited by this paper
• Investigation, treatment and monitoring of late-onset hypogonadism in males. ISA, ISSAM, and EAU recommendations.

  2005cited by this paper
• Restoration of couple's intimacy and relationship vital to reestablishing erectile function.

  2004cited by this paper
• Efficacy and safety of daily tadalafil in men with erectile dysfunction previously unresponsive to on-demand tadalafil.

  2004cited by this paper
• Long-term safety and tolerability of tadalafil in the treatment of erectile dysfunction.

  2004cited by this paper
• The multinational Men's Attitudes to Life Events and Sexuality (MALES) study: I. Prevalence oSf erectile dysfunction and related health concerns in the general population

  2004cited by this paper
• Endocrine aspects of sexual dysfunction in men.

  2004cited by this paper
• Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation.

  2004cited by this paper
• Understanding erectile dysfunction medication preference studies

  2004cited by this paper
• Common grounds for erectile dysfunction and coronary artery disease

  2004cited by this paper
• Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone.

  2004cited by this paper
• Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial.

  2004cited by this paper
• Peyronie's disease.

  2004cited by this paper
• Clinical experience with apomorphine hydrochloride: the first 107 patients.

  2003cited by this paper
• Sustained efficacy and tolerability of vardenafil, a highly potent selective phosphodiesterase type 5 inhibitor, in men with erectile dysfunction: results of a randomized, double-blind, 26-week placebo-controlled pivotal trial.

  2003cited by this paper
• American Urological Association guideline on the management of priapism.

  2003cited by this paper
• Oral testosterone undecanoate reverses erectile dysfunction associated with diabetes mellitus in patients failing on sildenafil citrate therapy alone

  2003cited by this paper
• Androgens improve cavernous vasodilation and response to sildenafil in patients with erectile dysfunction

  2003cited by this paper
• Safety and efficacy of vardenafil for the treatment of men with erectile dysfunction after radical retropubic prostatectomy.

  2003cited by this paper
• Effect of the angiotensin II antagonist valsartan on sexual function in hypertensive men

  2003cited by this paper
• Vardenafil, a new phosphodiesterase type 5 inhibitor, in the treatment of erectile dysfunction in men with diabetes: a multicenter double-blind placebo-controlled fixed-dose study.

  2003cited by this paper
• Phosphodiesterase type 5 as a pharmacologic target in erectile dysfunction.

  2002cited by this paper
• A 4-year update on the safety of sildenafil citrate (Viagra).

  2002cited by this paper
• Sildenafil for male erectile dysfunction: a systematic review and meta-analysis.

  2002cited by this paper
• Effect of antihypertensive treatment with valsartan or atenolol on sexual activity and plasma testosterone in hypertensive men

  2002cited by this paper
• Schedule 11 — impact on treating erectile dysfunction

  2002cited by this paper
• Efficacy and safety of tadalafil for the treatment of erectile dysfunction: results of integrated analyses.

  2002cited by this paper
• The Choice of Antihypertensive Drugs in Patients with Erectile Dysfunction

  2002cited by this paper
• A SYSTEMATIC APPROACH TO ERECTILE DYSFUNCTION IN THE CARDIOVASCULAR PATIENT: A CONSENSUS STATEMENT – UPDATE 2002

  2002cited by this paper
• Sexual activity in hypertensive men treated with valsartan or carvedilol: a crossover study.

  2001cited by this paper
• Double–Blind, Crossover Comparison of 3 mg Apomorphine SL with Placebo and with 4 mg Apomorphine SL in Male Erectile Dysfunction

  2001cited by this paper
• Lecture 3Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism

  2001cited by this paper
• Intracavernosal injection and intraurethral therapy for erectile dysfunction.

  2001cited by this paper
• Safety and tolerability of apomorphine SL in patients with erectile dysfunction

  2001cited by this paper
• Vacuum constriction and external erection devices in erectile dysfunction.

  2001cited by this paper
• Analysis of the consistency of intraurethral prostaglandin E(1) (MUSE) during at-home use.

  2001cited by this paper
• Clinical experience with intraurethral alprostadil (MUSE) in the treatment of men with erectile dysfunction. A retrospective study. Medicated urethral system for erection.

  2000cited by this paper
• Epidemiology of erectile dysfunction: results of the ‘Cologne Male Survey’

  2000cited by this paper
• Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?

  2000cited by this paper
• Sex hormones, obesity, fat distribution, type 2 diabetes and insulin resistance: epidemiological and clinical correlation

  2000cited by this paper
• Apomorphine: an update of clinical trial results

  2000cited by this paper
• The Female Sexual Response: A Different Model

  2000cited by this paper
• Incidence of erectile dysfunction in men 40 to 69 years old: longitudinal results from the Massachusetts male aging study.

  2000cited by this paper
• Clinical Experience with Intraurethral Alprostadil (MUSE®) in the Treatment of Men with Erectile Dysfunction

  2000cited by this paper
• Comparison of mechanical reliability of original and enhanced Mentor Alpha I penile prosthesis.

  1999cited by this paper
• Hemodynamic characterization of a functional erection. Arterial and corporeal veno-occlusive function in patients with a positive intracavernosal injection test.

  1999cited by this paper
• Sexual dysfunction in the United States: prevalence and predictors.

  1999cited by this paper
• Vacuum constriction devices for erectile dysfunction: a long-term, prospective study of patients with mild, moderate, and severe dysfunction.

  1999cited by this paper
• The causes of patient dropout from penile self-injection therapy for impotence.

  1999cited by this paper
• Sexual medicine in primary care

  1999cited by this paper
• A double blind, placebo controlled study of intracavernosal vasoactive intestinal polypeptide and phenotolamine mesylate in a novel auto-injector for the treatment of non-psychogenic erectile dysfunction

  1999cited by this paper
• Hemodynamic Characterization of a Functional Erection

  1999cited by this paper
• DISAPPOINTING INITIAL RESULTS WITH TRANSURETHRAL ALPROSTADIL FOR ERECTILE DYSFUNCTION IN A UROLOGY PRACTICE SETTING

  1999cited by this paper
• [Treatment for impotence].

  1998cited by this paper
• Sexual problems: a study of the prevalence and need for health care in the general population.

  1998cited by this paper
• Disappointing initial results with transurethral alprostadil for erectile dysfunction in a urology practice setting.

  1998cited by this paper
• Nocturnal penile tumescence and rigidity monitoring in young potent volunteers: reproducibility, evaluation criteria and the effect of sexual intercourse.

  1998cited by this paper
• Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group.

  1998cited by this paper
• Comparative study of papaverine plus phentolamine versus prostaglandin E1 in erectile dysfunction.

  1997cited by this paper
• Safety and efficacy outcome of mentor alpha-1 inflatable penile prosthesis implantation for impotence treatment.

  1997cited by this paper
• Treatment of men with erectile dysfunction with transurethral alprostadil. Medicated Urethral System for Erection (MUSE) Study Group.

  1997cited by this paper
• The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction.

  1997cited by this paper

• Sexual dysfunction and commonly used drugs in neurology

  2024cites this paper
• The indicative effects of apolipoproteins on organic erectile dysfunction: bridging Mendelian randomization and case-control study

  2024cites this paper
• THE ANALYSIS STUDY OF EFFECTIVENESS AND SAFETY OF ORAL SILDENAFIL CITRATE FOR TREATMENT OF ERECTILE DYSFUNCTION : A COMPREHENSIVE SYSTEMATIC REVIEW

  2024cites this paper
• Bioequivalence Studies of Sildenafil Citrate Orodispersible Film Administered with and without Water vs ViagraⓇ Film-Coated Tablets in Healthy Male Volunteers

  2023cites this paper
• Erectile dysfunction from mechanisms to medicines with a focus on the application of topical Minoxidil.

  2023cites this paper
• An Acceptance and Commitment Therapy Smartphone Application for Erectile Dysfunction: A Feasibility Study

  2023cites this paper
• Penilaian Erection Hardness Score Pasien Benign Prostatic Hyperplasia yang Ditangani dengan Tamsulosin dan Kombinasi Tamsulosin-Dutasteride

  2022cites this paper
• An update on the current status and future prospects of erectile dysfunction following radical prostatectomy

  2022cites this paper
• Men's Health Centers: An Emerging Paradigm of Sexual Function and Cardiometabolic Risk Reduction.

  2022cites this paper
• Acceptability of Health Professionals’ Address of Sexuality and Erectile Dysfunction - A Qualitative Interview Study with Men in Cardiac Rehabilitation

  2021cites this paper
• Bioequivalence and Bioavailability of an Orodispersible Tablet of Sildenafil Citrate in Healthy Chinese Male Subjects

  2020cites this paper
• Impact of Psychotropic Medications on Sexual Functioning

  2020cites this paper
• Considerations for prescribing pharmacotherapy for the treatment of erectile dysfunction

  2020cites this paper
• The Sextherapylondon interactive website for sexual difficulties: content, design and rationale

  2020cites this paper
• Pharmacology and perspectives in erectile dysfunction in man.

  2020cites this paper
• Apomorphine for the Treatment of Erectile Dysfunction: Systematic Review and Meta-Analysis

  2020cites this paper
• Management of erectile dysfunction after prostate cancer treatment: cross-sectional surveys of the perceptions and experiences of patients and healthcare professionals in the UK

  2019cites this paper
• Assessment of the effect of psoriasis on male sexual function

  2019cites this paper
• The Sextherapylondon interactive website for sexual difficulties: rationale, design and content

  2019cites this paper
• Physical activity as an adjunct treatment for erectile dysfunction

  2019cites this paper
• Diagnosis and Management of Erectile Dysfunction in Men

  2019cites this paper
• Erectile dysfunction: a global review of intracavernosal injectables

  2019cites this paper
• Current diagnosis and management of erectile dysfunction

  2019cites this paper
• Sexual dysfunction in patients with psoriasis

  2019cites this paper
• The 2018 Revision to the Process of Care Model for Evaluation of Erectile Dysfunction.

  2018cites this paper
• Sildenafil citrate use in Addis Ababa: characteristics of users and pharmacists’ dispensing practices

  2018cites this paper
• Erectile Dysfunction and Penile Rehabilitation After Robot-Assisted Radical Prostatectomy

  2018cites this paper
• British Society for Sexual Medicine Guidelines on the Management of Erectile Dysfunction in Men-2017.

  2018cites this paper
• Effects of the Severity of Erectile Dysfunction on Aortic Stiffness

  2018influential citation
• Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors

  2018cites this paper
• Sexual habits of men with ED who take phosphodiesterase 5 inhibitors: a survey conducted in 7 countries

  2018cites this paper
• Comparison of erectile dysfunction guidelines between the UK (BSSM/NICE) and Europe (EAU)

  2018cites this paper
• High prevalence of erectile dysfunction in men with psoriasis: evidence from a systematic review and meta-analysis

  2018cites this paper
• Edinburgh Research Explorer PROSPECTIV-a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors

  2018cites this paper
• Serum l-carnitine and vitamin D levels may be low among oral sildenafil citrate non-responders

  2018cites this paper
• Sexual function and cardiovascular disease: what the general cardiologist needs to know

  2018cites this paper
• Psoriasis and sexual dysfunction: links, risks, and management challenges

  2018cites this paper
• The Early Use of Vacuum Therapy for Penile Rehabilitation After Radical Prostatectomy: Systematic Review and Meta-Analysis

  2018cites this paper
• A prospective randomised placebo‐controlled study of the impact of dutasteride/tamsulosin combination therapy on sexual function domains in sexually active men with lower urinary tract symptoms (LUTS) secondary to benign prostatic hyperplasia (BPH)

  2018cites this paper
• The 2018 Revision to the Process of Care Model for Management of Erectile Dysfunction.

  2018cites this paper
• Resumen de la Guía de Práctica Clínica de Disfunción Eréctil – Sociedad Colombiana de Urología

  2018cites this paper
• Démarche diagnostique et prise en charge du patient souffrant de dysfonction érectile, actualisation et consignes pratiques

  2018cites this paper
• Sexual health and wellbeing

  2017cites this paper
• Serum testosterone: the why and wherefore of testing

  2017cites this paper
• Perceived Barriers to Addressing Sexual Issues Among Cardiovascular Patients

  2017cites this paper
• Male Sexual Rehabilitation After Pelvic Cancer

  2017cites this paper
• SMJERNICE ISKRA ZA DIJAGNOSTIKU I LIJEČENJE PROSTATITISA – HRVATSKE NACIONALNE SMJERNICE

  2017cites this paper
• The Graham Jackson Memorial Lecture ISSM 2016-"The Man Who Knew Too Much": Time to Recognize Erectile Dysfunction and Low Testosterone as Independent Risk Factors for Cardiovascular Disease.

  2017cites this paper
• The blue pill (sildenafil) and its descendants: an overview

  2017cites this paper
• Statin, testosterone and phosphodiesterase 5-inhibitor treatments and age related mortality in diabetes

  2017cites this paper
• Cardiovascular Disease Prevention in Men with Vascular Erectile Dysfunction: The View of the Preventive Cardiologist.

  2016cites this paper
• Predictors of Erectile Dysfunction in Men with Type 2 Diabetes Mellitus Referred to a Tertiary Healthcare Centre

  2016cites this paper
• Phosphodiesterase type 5 inhibitors: Irrational use in Saudi Arabia

  2016cites this paper
• Avanafil - a further step to tailoring patient needs and expectations

  2016cites this paper
• An ED patient with low testosterone

  2016cites this paper
• Mean platelet volume and platelet distribution as a diagnostic marker for penile vascular disease in patients with erectile dysfunction

  2016cites this paper
• Prevalence of metabolic syndrome and its components among men with and without clinical benign prostatic hyperplasia: a large, cross‐sectional, UK epidemiological study

  2016cites this paper
• Age, Body Mass Index, and Frequency of Sexual Activity are Independent Predictors of Testosterone Deficiency in Men With Erectile Dysfunction.

  2016cites this paper
• Erectile dysfunction in patients with plaque psoriasis: the relation of depression and cardiovascular factors

  2016cites this paper
• Testosterone Replacement Therapy and Mortality in Older Men

  2016cites this paper
• Health resource use after robot‐assisted surgery vs open and conventional laparoscopic techniques in oncology: analysis of English secondary care data for radical prostatectomy and partial nephrectomy

  2016cites this paper
• Coronary Heart Disease, Diabetes, and Sexuality in Men.

  2016cites this paper
• Psychotherapeutic interventions for sexual problems delivered via the Internet: Effectiveness, acceptability and reach

  2016cites this paper
• Serum testosterone, testosterone replacement therapy and all‐cause mortality in men with type 2 diabetes: retrospective consideration of the impact of PDE5 inhibitors and statins

  2016cites this paper
• Role of 2D Strain in the Early Identification of Cardiac Dysfunction and in the Risk Stratification of Arteriogenic Erectile Dysfunction Patients.

  2016cites this paper
• The evaluation of the patient with erectile dysfunction

  2016cites this paper
• Erectile dysfunction, diabetes and cardiovascular risk

  2016cites this paper
• Subclinical left ventricular deterioration in patients with erectile dysfunction

  2016cites this paper
• Attitudes and Performance of Cardiologists Toward Sexual Issues in Cardiovascular Patients

  2016cites this paper
• Diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome

  2015cites this paper
• Guía de disfunción eréctil. Sociedad Colombiana de Urología

  2015cites this paper
• Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors

  2015cites this paper
• Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors

  2015cites this paper
• An integrated approach with vardenafil orodispersible tablet and cognitive behavioral sex therapy for treatment of erectile dysfunction: a randomized controlled pilot study

  2015cites this paper
• Erectile dysfunction: a window to the heart

  2015cites this paper
• The Circle of Lifestyle and Erectile Dysfunction.

  2015cites this paper
• Symptoms, unmet needs, psychological well‐being and health status in survivors of prostate cancer: implications for redesigning follow‐up

  2015cites this paper
• Does alprostadil cream hit the spot?

  2015cites this paper
• Diagnosis and treatment of chronic prostatitis/chronic pelvic pain syndrome

  2015cites this paper
• Symptoms, unmet needs, psychological well-being and health status in prostate cancer survivors

  2015cites this paper
• Acromegaly Presenting as Erectile Dysfunction: Case Reports and Review of the Literature.

  2015cites this paper
• Should PDE5Is be prescribed routinely for all men with newly diagnosed type 2 diabetes

  2015cites this paper
• NOVEL + EMERGING RISK FACTORS ( K NASIR , SECTION EDITOR ) Erectile Dysfunction : an Early Sign of Cardiovascular Disease

  2015cites this paper
• Basic Principles of the Princeton Recommendations

  2015cites this paper
• Lipid Peroxidation and Antioxidant System in Men with Urogenital Lesions after Stomach Resection

  2015cites this paper
• Lifestyle Modification in Erectile Dysfunction and Hypertension

  2015cites this paper
• Diabetes Mellitus and Erectile Dysfunction

  2015cites this paper
• Testosterone replacement therapy improves metabolic parameters in hypogonadal men with type 2 diabetes but not in men with coexisting depression: the BLAST study.

  2014cites this paper
• WOMEN'S PERCEPTION OF THEIR HUSBANDS' TREATMENT OF ERECTILE DYSFUNCTION

  2014cites this paper
• Safety and efficacy of 20 mg pentadafil in Egyptian male patients with erectile dysfunction: a randomized, double-blinded, placebo-controlled, multicenter study

  2014cites this paper
• Sexual wellbeing for people with chronic obstructive pulmonary disease: relevance and roles for physiotherapy

  2014cites this paper
• Erectile Dysfunction and Infertility

  2014cites this paper
• Sexual Dysfunction Related to Drugs : A Critical

  2014cites this paper
• PROSPECTIV—a pilot trial of a nurse-led psychoeducational intervention delivered in primary care to prostate cancer survivors: study protocol for a randomised controlled trial

  2014cites this paper
• Erectile Dysfunction and Cardiovascular Assessment

  2014cites this paper
• Treatment strategies for diabetic patients suffering from erectile dysfunction: an update

  2014cites this paper
• Sexual Dysfunction Related to Drugs: A Critical Review. Part IV: Cardiovascular Drugs

  2014cites this paper
• Erectile dysfunction in primary care: a focus on cardiometabolic risk evaluation and stratification for future cardiovascular events.

  2014cites this paper
• Management of ED under the "severe distress" criteria in the NHS: a real-life study.

  2014cites this paper
• Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer

  2014cites this paper